analgesics (Kareus Therapeutics)

N/A

Report date: 2025/01/26 19:01:04
NME

Base Information

Drug Nameanalgesics (Kareus Therapeutics)
Drug Alias NameDMARD (Kareus Therapeutics)anti-inflammatory therapeutics (Kareus Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsPainInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKareus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesKareus Therapeutics
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsInflammationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A